Mikatop 250mg Injection
Marketer
Progressive Life Care
Salt Composition
Amikacin (250mg)
Overview Mikatop 250mg Injection
Cefamandole nafate 250mg injection combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (including pneumonia), brain, and bloodstream infections. Prophylactically, it's used in hospitalized individuals to ward off infection. Its mechanism involves inhibiting bacterial growth. Administered intravenously via infusion or direct injection (intramuscular or intravenous), it requires professional medical oversight and should never be self-administered. Adherence to the prescribed dosage schedule is crucial; consistent, evenly-spaced doses are essential. Complete the entire course, even with symptom improvement, as premature cessation risks relapse or exacerbation. Common adverse reactions include injection site inflammation and elevated blood urea nitrogen (BUN). Persistent side effects or treatment inefficacy warrant immediate medical consultation. High doses may induce disequilibrium, renal impairment, and auditory deficits. Strict adherence to physician instructions is paramount, often including regular assessments of kidney function, hearing, and urinalysis. Pregnancy contraindicates its use; inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Mikatop 250mg Injection
Infections caused by bacteria
Major Benefits of Mikatop 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Mikatop 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikatop 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Mikatop 250mg Injection works:
Mikatop 250mg injection is a bactericidal medication. Its mechanism of action involves inhibiting the production of crucial bacterial proteins, thereby disrupting essential bacterial processes.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Mikatop 250mg Injection presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikatop 250mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in extraordinary circumstances where a physician deems the potential benefits outweigh the inherent dangers to the mother's life. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use Mikatop 250mg Injection safely. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administering Mikatop 250mg Injection could lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Administering Mikatop 250mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Mikatop 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mikatop 250mg Injection in patients with liver impairment appears to pose minimal risk. Existing evidence indicates that dose modification may not be necessary for this population. However, physician consultation is recommended.
What if you forget to take Mikatop 250mg Injection :
Omit a Mikatop 250mg Injection dose? Seek medical advice immediately.
Facts to Know About Mikatop 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently